BBS1 Antibody

Code CSB-PA836736LA01HU
Size US$166
Order now
Image
  • Western Blot
    Positive WB detected in: Mouse lung tissue
    All lanes: BBS1 antibody at 1μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 66, 70, 50 kDa
    Observed band size: 66 kDa

  • Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA836736LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human liver tissue using CSB-PA836736LA01HU at dilution of 1:100

  • Immunofluorescent analysis of HepG2 cells using CSB-PA836736LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) BBS1 Polyclonal antibody
Uniprot No.
Target Names
BBS1
Alternative Names
AI451249 antibody; Bardet-Biedl syndrome 1 antibody; Bardet-Biedl syndrome 1 homolog antibody; Bardet-Biedl syndrome 1 protein antibody; BBS1 antibody; BBS1_HUMAN antibody; BBS2-like protein 2 antibody; BBS2L2 antibody; D19Ertd609e antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human Bardet-Biedl syndrome 1 protein (217-417AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The BBS1 Antibody (Product code: CSB-PA836736LA01HU) is Non-conjugated. For BBS1 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA836736LB01HU BBS1 Antibody, HRP conjugated ELISA
FITC CSB-PA836736LC01HU BBS1 Antibody, FITC conjugated
Biotin CSB-PA836736LD01HU BBS1 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization. Plays a role in olfactory cilium biogenesis/maintenance and trafficking.
Gene References into Functions
  1. Importantly, one Japanese and one Omani families carried compound biallelic mutations in two distinct genes (TMEM67/RPGRIP1L and TMEM138/BBS1, respectively). PMID: 27434533
  2. M390R mutation in BBS1 reduces surface expression of insulin receptor in fibroblasts derived from BBS patients. PMID: 26103456
  3. BBS1 emerged as a novel predictor of overall survival in MPM. PMID: 26254420
  4. Bardet-Biedl syndrome patients with missense mutations in BBS1 have lower biochemical cardiovascular disease markers compared with patients with BBS10 and other BBS1 mutations. PMID: 24611735
  5. We report a case in which whole-exome sequencing in a patient previously suspected to have Usher syndrome revealed disease-causing mutations in BBS1 and SLC26A4. PMID: 26022370
  6. A homozygous BBS1 p.M390R mutation is associated with Bardet-Biedl syndrome. PMID: 25494902
  7. novel BBS1 mutations in Bardet-Biedl syndrome patients in Spain PMID: 24611592
  8. Results show that BBS1 and BBS3 regulates the ciliary traficking of PC1. PMID: 24939912
  9. mediates endosomal recycling, sorting and signal transduction of Notch receptors PMID: 24681783
  10. Novel mutations (c.1110G>A and c.39delA (p.G13fs*41)) in BBS1 found in Tunisian families with Bardet-Biedl syndrome. PMID: 23432027
  11. loss of BBS1, BBS4, or OFD1 led to decreased NF-kappaB activity and concomitant IkappaBbeta accumulation and that these defects were ameliorated with SFN treatment. PMID: 24691443
  12. Exome sequencing identified a novel homozygous mutation (c.47+1G>T) in BBS1 that inactivates the splice donor site at the end of exon 1. PMID: 23559858
  13. Our findings confirm the consistent pathogenicity of the BBS1 M390R mutation in Bardet-Biedl syndrome in patients homozygous for the common M390R mutation in the BBS1 gene. PMID: 22940089
  14. Variants in BBS1 are significantly associated with nonsyndromic autosomal recessive RP and relatively mild forms of BBS. PMID: 23143442
  15. Patients with BBS1 mutations had a milder phenotype than did patients with mutations in other BBS genes. PMID: 22410627
  16. this report describes the identification and characterization of a splice donor site mutation that leads to missplicing of BBS1 transcripts in Bardet-Biedl syndrome. PMID: 21520335
  17. This protein has amino acid sequence homolgy with mice. Missense mutation accounts for about 80% of all BBS1 mutations on a similar genetic background across populations. PMID: 12524598
  18. Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with this protein. PMID: 12567324
  19. BBS1 participates in complex inheritance and in different families, mutations in BBS1 can interact genetically with mutations at each of the other known BBS genes, as well as at unknown loci, to cause the phenotype PMID: 12677556
  20. The presence of three mutant alleles in the BBS family correlates with a more severe Bardet-Biedl phenotype. PMID: 12837689
  21. disease-associated alleles occur at relatively high frequencies in normal haplotypes PMID: 15517396
  22. The cardinal feature of retinal degeneration in BBS1 can show a wide spectrum of disease expression. PMID: 17065520
  23. A novel BBS1 mutation was identified, most probably a founder mutation, further confirming the Faroe Islands as a genetic isolate. PMID: 18669544
  24. Although neither proband fulfilled the typical criteria for BBS, this diagnosis was confirmed on mutation analysis. PMID: 18766993

Show More

Hide All

Involvement in disease
Bardet-Biedl syndrome 1 (BBS1)
Subcellular Location
Cell projection, cilium membrane. Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite.
Tissue Specificity
Highly expressed in the kidney. Also found in fetal tissue, testis, retina, adipose tissue, heart, skeletal muscle and pancreas.
Database Links

HGNC: 966

OMIM: 209900

KEGG: hsa:582

STRING: 9606.ENSP00000317469

UniGene: Hs.502915

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*